The relationship between the level of serum uric acid and no-reflow phenomenon after primary percutaneous coronary intervention in patients with St segment elevated myocardial infarction

Basit Öğe Kaydı
dc.authorscopusid8650271300
dc.authorscopusid35069277300
dc.authorscopusid15052469100
dc.authorscopusid36084223000
dc.authorscopusid35787092000
dc.authorscopusid35338946100
dc.contributor.authorErden, Ismail
dc.contributor.authorErden, Emine Çakcak
dc.contributor.authorSözen, Serhat Bahadir
dc.contributor.authorKayapinar, Osman
dc.contributor.authorÇa?lar, Sabri Onur
dc.contributor.authorBaşar, Cengiz
dc.date.accessioned2024-09-25T19:45:19Z
dc.date.available2024-09-25T19:45:19Z
dc.date.issued2010
dc.departmentAbant İzzet Baysal Üniversitesien_US
dc.description.abstractNo-reflow phenomenon is the absence of myocardial perfusion despite adequate dilatation of the infarct related coronary artery during percutaneous coronary intervention. Uric acid (UA) release during ischemia and washout from the ischemic zone during reperfusion is adenine nucleotide breakdown product. Therefore uric acid may play reperfusion injury and no-reflow. İn this study, we aimed to compare serum uric acid value of ST segment elevated Mİ patients groups whith no-reflow phenomenon and normal miyocardial perfusion after primary coronary intervention. 47 patients was enrolled consecutively to this study. During hospital admission, patients blood samples were taken for serum uric acid value. Patients was grouped as no reflow and normal perfusion groups according to myocardial blush grades (MBG). Patient with myocardial blush grades 0-1 were accepted as no-reflow group, patients with MBG 2-3 normal perfusion group. When the serum uric acid value of no-reflow and normal perfusion groups was compared, there was statistificaly significant difference (respectively 6,680±1,11 mg/dl versus 5,066±0,68 mg/dl. p<0,05). A significant correlation was found between the serum uric acid level and the presence of no-reflow phenomenon (r=0.598; p<0.025). Multivariate logistic regression analysis showed an independent relationship between no-reflow phenomenon and serum uric acid level (OR 1.815; 95% CI 1.098-1.493; p<0.031). In ST segment elevated Mİ patients with higher serum uric acid value before primary coronary intervention, no-reflow phenomenon is developed more frequently. Uric acid may play important role in mechanism of no-reflow phenomenon. © 2010 Düzce Medical Journal.en_US
dc.identifier.endpage44en_US
dc.identifier.issn1307-671X
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-78449263262en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage40en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12491/12975
dc.identifier.volume12en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofDuzce Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzYK_20240925en_US
dc.subjectAcute myocardial infarctionen_US
dc.subjectNo-reflowen_US
dc.subjectPrimary coronary interventionen_US
dc.subjectUric aciden_US
dc.titleThe relationship between the level of serum uric acid and no-reflow phenomenon after primary percutaneous coronary intervention in patients with St segment elevated myocardial infarctionen_US
dc.title.alternativeSt elevasyonlu miyokard i?nfarktüslü hastalarda primer perkütan girişim sonrasi no-reflow fenomeni gelişimi ile serum ürik asit düzeyleri arasindaki i?lişki]en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu